![]()
马俊杰
-
副教授
硕士生导师
- 性别：男
- 学历：博士研究生
- 学位：理学博士学位
- 入职时间：2015-07-16
- 所在单位：华侨大学医学院
- 电子邮箱：095a856ffaf8f8d473e9d989c8593835dd4687851493dd97bd2582699d0cb93d7a6e1080925dfdf0ae704b4abc3974409832a538b1bb4ab4841bdab0670a2268bfce03e72f335175628059f3d49e78e2b9f5229853d199c573f96525ec09bd58d92665ce45c44a8bc6973dc69fc64e76eb2a423d2b367faf807f9deef4b2aba8
- 在职信息：在岗
访问量：
-
[1]Design, synthesis, evaluation and molecular modeling of quinazoline derivatives bearing amino acids as small-molecule PD-L1 inhibitors.[J].Journal of Computer-Aided Molecular Design,2025,39:55.
-
[2]Discovery of novel biphenyl compounds bearing hydroxamic acid moiety as the first PD-L1/class I HDACs dual inhibitors.[J].Journal of Enzyme Inhibition and Medicinal Chemistry,2025,40(1):2461190.
-
[3]Design, Synthesis, and Evaluation of 8-(o-Tolyl)quinazoline Derivatives as Small-Molecule PD-1/PD-L1 Antagonists.ACS Medicinal Chemistry Letters,2024,15518-523.
-
[4]Design, synthesis and biological evaluation of VEGFR-2/HDAC dual inhibitors as multitargeted antitumor agents based on fruquintinib and vorinostat.RSC Adv.,2023,1328462-28480.
-
[5]Advances in nonclassical phenyl bioisosteres for drug structural optimization.Future Medicinal Chemistry,2022,141681-1692.
-
[6]Advances in research on 3C-like protease (3CLpro) inhibitors against SARS-CoV-2 since 2020.RSC Med. Chem.,2022,149-21.
-
[7]Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction.European Journal of Medicinal Chemistry,2022,229113998.
-
[8]Advances of biphenyl small-molecule inhibitors targeting PD-1/PD-L1 interaction in cancer immunotherapy.Future Med. Chem.,2021,1497-113.
-
[9]Design, Synthesis, Biological Activity and Molecular Docking Study of Coumarin Derivatives Bearing 2-Methyl-Biphenyl Moiety.Chem. Res. Chinese Universities,2019,35410-417.
-
[10]Semicarbazone derivatives bearing phenyl moiety: synthesis, anticancer activity, cell cycle, apoptosis-inducing and metabolic stability study.Chemical & Pharmaceutical Bulletin,2019,67351-360.
